Core Viewpoint - The company New Hope (新诺威) has signed a share transfer agreement with CSPC Pharmaceutical Group Limited (石药控股) to sell 30.0704% of its shares in Beijing Guoxin Huijin Co., Ltd. for 230 million yuan, aiming to optimize its asset structure and improve operational efficiency [1] Group 1 - The share transfer is based on a comprehensive consideration of the company's development situation, which will help optimize resource allocation and focus on core business [1] - The transaction is expected to enhance the company's financial structure, reduce operational risks, and promote high-quality development [1] - Proceeds from the share transfer will be used to supplement the company's daily operational funds, supporting business development in line with the company's long-term strategic planning [1]
新诺威拟出售国新汇金30.0704%股份,作价2.3亿元